(Q28176000)

2

object named as

A Undas

0 references

author name string

J Musial

1

0 references

P Gajewski

3

0 references

M Jankowski

4

0 references

W Sydor

International Journal of Cardiology

5

0 references

language of work or name

English

0 references

publication date

February 2001

0 references

published in

0 references

volume

77

0 references

issue

2-3

0 references

page(s)

247-53

0 references

cites work

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

Low density lipoprotein oxidation and its pathobiological significance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

The acute phase response

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

Statins do more than just lower cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

Effect of statins on C-reactive protein in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

Inhibition of proinflammatory cytokine production by pravastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

HMG-CoA Reductase Inhibitors Decrease CD11b Expression and CD11b-Dependent Adhesion of Monocytes to Endothelium and Reduce Increased Adhesiveness of Monocytes Isolated From Patients With Hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

A study of the influence of various antirheumatic drug regimens on serum acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

C-reactive protein in the serial assessment of disease activity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

Inflammation, Aspirin, and the Risk of Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

Aspirin inhibits inducible nitric oxide synthase expression and tumour necrosis factor-alpha release by cultured smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900439-3

7 January 2021

10.1016/S0167-5273(00)00439-3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

3046730

3046730

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference